BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19053130)

  • 1. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.
    Guggenheim ER; Xu D; Zhang CX; Chang PV; Lippard SJ
    Chembiochem; 2009 Jan; 10(1):141-57. PubMed ID: 19053130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA.
    Guggenheim ER; Ondrus AE; Movassaghi M; Lippard SJ
    Bioorg Med Chem; 2008 Dec; 16(23):10121-8. PubMed ID: 18977144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling.
    Zhang CX; Chang PV; Lippard SJ
    J Am Chem Soc; 2004 Jun; 126(21):6536-7. PubMed ID: 15161265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin-DNA interstrand cross-links.
    Zhu G; Lippard SJ
    Biochemistry; 2009 Jun; 48(22):4916-25. PubMed ID: 19364127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
    Zhu G; Chang P; Lippard SJ
    Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Ang WH; Myint M; Lippard SJ
    J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.
    Wei M; Cohen SM; Silverman AP; Lippard SJ
    J Biol Chem; 2001 Oct; 276(42):38774-80. PubMed ID: 11514569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
    Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
    Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
    Chow CS; Barnes CM; Lippard SJ
    Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.
    Jung Y; Lippard SJ
    J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
    Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB; Mu D; Reardon JT; Sancar A; Lippard SJ
    Biochemistry; 1996 Aug; 35(31):10004-13. PubMed ID: 8756462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
    Cohen SM; Mikata Y; He Q; Lippard SJ
    Biochemistry; 2000 Sep; 39(38):11771-6. PubMed ID: 10995245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG domain proteins induce sharp bends in cisplatin-modified DNA.
    Chow CS; Whitehead JP; Lippard SJ
    Biochemistry; 1994 Dec; 33(50):15124-30. PubMed ID: 7999772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).
    Treiber DK; Zhai X; Jantzen HM; Essigmann JM
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5672-6. PubMed ID: 8202546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G; Myint M; Ang WH; Song L; Lippard SJ
    Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
    Wang D; Hara R; Singh G; Sancar A; Lippard SJ
    Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein.
    Fourrier L; Brooks P; Malinge JM
    J Biol Chem; 2003 Jun; 278(23):21267-75. PubMed ID: 12654906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.